Free Trial

Kyverna Therapeutics (KYTX) Institutional Ownership

Kyverna Therapeutics logo
$5.05 +0.02 (+0.40%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$5.26 +0.21 (+4.16%)
As of 11/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)

Current
Institutional Ownership
Percentage
18.08%
Number of
Institutional Buyers
(last 12 months)
70
Total
Institutional Inflows
(last 12 months)
$162.65M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$13.60M
Get KYTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2026Marshall Wace LLP73,276$498K0.0%N/A0.118%
11/13/2026Empowered Funds LLC18,683$127K0.0%N/A0.030%
11/13/2026Kovack Advisors Inc.10,000$65K0.0%N/A0.016%
11/12/2026 State Street Corp1,203,252$8.18M0.0%-38.7%1.946%
11/7/2026 ACT Capital Partners L.P.40,000$272K0.2%N/A0.065%
11/2/2026 AIGH Capital Management LLC3,650,000$24.82M2.5%+30.6%5.902%
10/28/2026 North Star Investment Management Corp.10,000$68K0.0%N/A0.000%
10/26/2026 Oppenheimer & Co. Inc.11,500$78K0.0%N/A0.019%
10/17/2026 IFP Advisors Inc29,000$197K0.0%+132.0%0.047%
10/13/2026 Baldwin Wealth Partners LLC MA13,969$95K0.0%N/A0.023%
9/9/2026 WINTON GROUP Ltd17,400$155K0.0%N/A0.028%
9/9/2026 IFP Advisors Inc12,500$111K0.0%N/A0.020%
9/9/2026 Squarepoint Ops LLC82,867$738K0.0%-43.6%0.134%
9/8/2026Spark Investment Management LLC25,100$224K0.4%N/A0.041%
9/2/2026Allianz Asset Management GmbH11,000$98K0.0%N/A0.018%
8/20/2026Susquehanna Fundamental Investments LLC45,360$404K0.0%N/A0.073%
8/19/2026Wellington Management Group LLP117,442$1.05M0.0%N/A0.190%
8/17/2026Bank of America Corp DE265,405$2.37M0.0%N/A0.429%
8/15/2026Man Group plc68,640$612K0.0%N/A0.111%
8/14/2026Canada Pension Plan Investment Board40,000$356K0.0%N/A0.065%
8/14/2026Legal & General Group Plc4,072$36K0.0%N/A0.007%
8/14/2026The Manufacturers Life Insurance Company82,207$732K0.0%N/A0.133%
8/12/2026 Quantbot Technologies LP21,287$190K0.0%N/A0.035%
8/7/2026BlackRock Inc.3,134,807$27.93M0.0%N/A5.157%
8/7/2026 Deutsche Bank AG44,853$400K0.0%N/A0.074%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.25,741$229K0.0%N/A0.042%
8/7/2026 AIGH Capital Management LLC2,795,797$24.91M1.6%N/A4.599%
8/6/2026 Bank of New York Mellon Corp100,281$894K0.0%N/A0.165%
8/6/2026 State of Wyoming10,849$97K0.0%N/A0.018%
8/3/2026Walleye Capital LLC245,587$2.19M0.0%N/A0.404%
5/19/2026Bank of America Corp DE55,728$481K0.0%+94.1%0.092%
5/18/2026ADAR1 Capital Management LLC22,428$194K0.0%-60.9%0.037%
5/15/2026OMERS ADMINISTRATION Corp14,800$128K0.0%-57.5%0.024%
5/14/2026 Renaissance Technologies LLC367,492$3.17M0.0%+106.6%0.605%
5/14/2026Walleye Capital LLC38,196$330K0.0%N/A0.063%
5/6/2026Kera Capital Partners Inc.108,083$933K0.1%-18.5%0.179%
4/30/2026 AIGH Capital Management LLC2,000,000$17.26M2.4%+33.3%3.304%
4/27/2026 Simplify Asset Management Inc.173,106$1.49M0.0%-10.0%0.286%
4/27/2026 Y Intercept Hong Kong Ltd114,841$991K0.0%N/A0.190%
4/21/2026 Wesbanco Bank Inc.110,300$952K0.0%N/A0.182%
Today's free pick (on me) (Ad)

Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel

Get today's free pick before December 8th.
4/21/2026 Grey Ledge Advisors LLC10,000$86K0.0%N/A0.017%
4/20/2026 Banque Cantonale Vaudoise30,532$263K0.0%N/A0.050%
2/23/2026Kera Capital Partners Inc.132,603$1.25M0.2%-68.6%0.303%
2/18/2026Empowered Funds LLC17,935$169K0.0%N/A0.041%
2/18/2026XTX Topco Ltd23,282$219K0.0%-52.6%0.053%
2/18/2026Quadrature Capital Ltd57,369$539K0.0%N/A0.131%
2/18/2026Millennium Management LLC593,369$5.58M0.0%+7.6%1.355%
2/18/2026Balyasny Asset Management L.P.980,869$9.22M0.0%N/A2.239%
2/18/2026683 Capital Management LLC114,900$1.08M0.0%N/A0.262%
2/18/2026ACT Capital Management LLC25,100$236K0.2%N/A0.057%
2/17/2026ADAR1 Capital Management LLC57,428$540K0.0%N/A0.131%
2/17/2026Schonfeld Strategic Advisors LLC28,872$271K0.0%N/A0.066%
2/17/2026Burkehill Global Management LP200,000$1.88M0.1%N/A0.457%
2/17/2026Bain Capital Life Sciences Investors LLC3,110,000$29.23M2.2%-7.7%7.100%
2/17/2026Jump Financial LLC80,299$755K0.0%N/A0.183%
2/17/2026Heights Capital Management Inc.271,822$2.56M0.9%N/A0.621%
2/17/2026Price T Rowe Associates Inc. MD1,762,617$16.57M0.0%+16.6%4.024%
2/17/2026Adage Capital Partners GP L.L.C.1,666,666$15.67M0.0%N/A3.805%
2/16/2026OMERS ADMINISTRATION Corp34,800$327K0.0%N/A0.079%
2/16/2026 Squarepoint Ops LLC138,868$1.31M0.0%N/A0.317%
2/16/2026Maven Securities LTD146,400$1.38M0.0%N/A0.334%
2/16/2026 Barclays PLC164,668$1.55M0.0%+116.1%0.376%
2/13/2026Marshall Wace LLP135,600$1.28M0.0%N/A0.310%
2/13/2026The Manufacturers Life Insurance Company 134,530$1.26M0.0%+29.6%0.307%
2/13/2026 Stifel Financial Corp125,790$1.18M0.0%+224.0%0.287%
2/13/2026Hudson Bay Capital Management LP88,553$832K0.0%N/A0.202%
2/13/2026Alyeska Investment Group L.P.600,000$5.64M0.0%N/A1.370%
2/13/2026Wells Fargo & Company MN74,949$705K0.0%+310.0%0.171%
2/12/2026 Renaissance Technologies LLC177,899$1.67M0.0%+8.1%0.406%
2/12/2026 Dimensional Fund Advisors LP78,413$737K0.0%N/A0.179%
2/12/2026EntryPoint Capital LLC10,048$94K0.0%N/A0.023%
2/12/2026 Federated Hermes Inc.20,705$195K0.0%+36.6%0.047%
2/12/2026 Monashee Investment Management LLC195,000$1.83M1.0%N/A0.445%
2/11/2026Empowered Funds LLC17,935$169K0.0%N/A0.041%
2/11/2026Propel Bio Management LLC666,666$6.27M5.4%N/A1.522%
2/10/2026TD Asset Management Inc222,796$2.09M0.0%+35.2%0.509%
2/10/2026Goldman Sachs Group Inc.133,530$1.26M0.0%+209.6%0.305%
2/9/2026 Geode Capital Management LLC266,402$2.51M0.0%-4.3%0.608%
2/9/2026 Simplify Asset Management Inc.192,339$1.81M0.0%N/A0.439%
2/9/2026Jefferies Financial Group Inc.32,001$301K0.0%+96.3%0.073%
2/6/2026Nano Cap New Millennium Growth Fund L P53,500$503K0.4%N/A0.122%
2/3/2026 RFG Advisory LLC445,200$4.19M0.1%N/A1.017%
2/2/2026 AIGH Capital Management LLC1,500,000$14.10M3.4%N/A3.425%
1/28/2026 Peapod Lane Capital LLC183,820$1.73M1.5%-42.3%0.420%
1/22/2026 Phoenix Wealth Advisors12,300$116K0.0%+17.1%0.028%
1/1/2026 JPMorgan Chase & Co.6,675$40K0.0%-76.0%0.015%
11/17/2025Jacobs Levy Equity Management Inc.147,712$886K0.0%N/A0.337%
11/17/2025Woodline Partners LP252,212$1.51M0.0%N/A0.576%
11/17/2025Qube Research & Technologies Ltd36,691$220K0.0%+161.1%0.084%
11/17/2025Prelude Capital Management LLC19,438$117K0.0%-46.4%0.044%
My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
11/17/2025Public Employees Retirement System of Ohio4,600$28K0.0%N/A0.011%
11/17/2025Millennium Management LLC551,635$3.31M0.0%+21.9%1.259%
11/17/2025Bank of America Corp DE64,964$390K0.0%+92.5%0.148%
11/17/2025Ameriprise Financial Inc.12,882$77K0.0%N/A0.029%
11/14/2025Two Sigma Investments LP132,451$795K0.0%+9.8%0.306%
11/14/2025Bridgeway Capital Management LLC174,900$1.05M0.0%+178.1%0.404%
11/13/2025 UBS Group AG157,422$945K0.0%+60.4%0.364%
11/13/2025 BNP Paribas Financial Markets34,022$204K0.0%+667.8%0.079%
11/13/2025 Franklin Resources Inc.677,587$4.07M0.0%-2.5%1.567%
11/13/2025Jefferies Financial Group Inc.16,300$98K0.0%N/A0.038%


KYTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 106 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($29.23M), BlackRock Inc. ($27.93M), AIGH Capital Management LLC ($24.82M), Price T Rowe Associates Inc. MD ($16.57M), Adage Capital Partners GP L.L.C. ($15.67M), Gilead Sciences Inc. ($15.43M), and Balyasny Asset Management L.P. ($9.22M).Learn more on Kyverna Therapeutics' institutional investors.

18.08% of Kyverna Therapeutics' stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings.

Of the 103 institutional investors that purchased Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($5.65M), Gilead Sciences Inc. ($4.13M), BlackRock Inc. ($3.13M), Adage Capital Partners GP L.L.C. ($1.67M), Balyasny Asset Management L.P. ($980.87K), Propel Bio Management LLC ($666.67K), and Jacobs Levy Equity Management Inc. ($609.67K).

Institutional investors have bought a total of 18,251,571 shares in the last 24 months. This purchase volume represents approximately $162.65M in transactions.

Of the 12 institutional investors that sold Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($761.21K), Kera Capital Partners Inc. ($313.84K), Bain Capital Life Sciences Investors LLC ($258.37K), Peapod Lane Capital LLC ($134.94K), Squarepoint Ops LLC ($64.11K), ADAR1 Capital Management LLC ($35K), and XTX Topco Ltd ($25.83K).

Institutional investors have sold a total of 1,682,450 shares in the last 24 months. This volume of shares sold represents approximately $13.60M in transactions.



Institutional ownership data for NASDAQ:KYTX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 11/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners